Need Help?

A3164_ClariomD

ALL SAMPLES USING ClariomD microarray (Affymetrix)

Request Access

Amazentis Data Access Agreement. Please request a word template of the Data Access Policy when needed.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom AMAZENTIS grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: AMAZENTIS and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. AMAZENTIS: Mailing address: EPFL Innovation Park, Building C, CH-1015 Lausanne e-mail: contact@amazentis.com Phone: +41 21 552 12 70 Website: www.amazentis.com 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify AMAZENTIS within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify AMAZENTIS prior to any significant changes to the protocol for the Project. 14. The User Institution will notify AMAZENTIS as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. AMAZENTIS may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than AMAZENTIS. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for AMAZENTIS Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS Dataset reference (EGA Study ID and Dataset Details) EGA Study ID: EGAS00001003638 Study title: Effect of 28-day administration of Urolithin A to sedentary elderly on muscle gene expression Details: Urolithin A was administered for 28-day in a first-in-human clinical trial to sedentary elderly subjects. Muscle biopsies were collected before the first dosing, and at the end of the 28-day period, under fasted conditions. Gene expression was measured by microarray. This encompasses one (1) dataset of 72 microarrays performed using human muscle mRNA. Name of project that created the dataset A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects (NCT02655393) Names of other data producers/collaborators Anurag Singh Pénélope Andreux Specific limitations on areas of research No specific limitations on areas of research are bound to this dataset. Minimum protection measures required File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY AMAZENTIS intend to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. AMAZENTIS anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until 12 months after these data were first made available on the relevant hosting database, unless AMAZENTIS has provided written consent to earlier submission. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with AMAZENTIS.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003638 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002458267 CEL 70.3 MB
EGAF00002458268 CEL 69.5 MB
EGAF00002458269 CEL 69.6 MB
EGAF00002458270 CEL 69.5 MB
EGAF00002458271 CEL 69.6 MB
EGAF00002458272 CEL 69.6 MB
EGAF00002458273 CEL 69.5 MB
EGAF00002458274 CEL 69.4 MB
EGAF00002458275 CEL 69.7 MB
EGAF00002458276 CEL 69.7 MB
EGAF00002458277 CEL 69.5 MB
EGAF00002458278 CEL 69.6 MB
EGAF00002458279 CEL 69.7 MB
EGAF00002458280 CEL 69.5 MB
EGAF00002458281 CEL 69.4 MB
EGAF00002458282 CEL 69.5 MB
EGAF00002458283 CEL 69.6 MB
EGAF00002458284 CEL 69.5 MB
EGAF00002458285 CEL 69.9 MB
EGAF00002458286 CEL 69.5 MB
EGAF00002458287 CEL 69.6 MB
EGAF00002458288 CEL 69.5 MB
EGAF00002458289 CEL 69.4 MB
EGAF00002458290 CEL 69.6 MB
EGAF00002458291 CEL 69.8 MB
EGAF00002458292 CEL 69.5 MB
EGAF00002458293 CEL 69.3 MB
EGAF00002458294 CEL 69.5 MB
EGAF00002458295 CEL 69.6 MB
EGAF00002458296 CEL 69.4 MB
EGAF00002458297 CEL 69.6 MB
EGAF00002458298 CEL 69.5 MB
EGAF00002458299 CEL 69.6 MB
EGAF00002458300 CEL 70.1 MB
EGAF00002458301 CEL 69.5 MB
EGAF00002458302 CEL 69.6 MB
EGAF00002458303 CEL 69.6 MB
EGAF00002458304 CEL 69.6 MB
EGAF00002458305 CEL 69.5 MB
EGAF00002458306 CEL 70.1 MB
EGAF00002458307 xlsx 90.4 MB
EGAF00002458308 CEL 70.1 MB
EGAF00002458309 CEL 69.4 MB
EGAF00002458310 CEL 69.6 MB
EGAF00002458311 CEL 69.7 MB
EGAF00002458312 CEL 70.0 MB
EGAF00002458313 CEL 69.5 MB
EGAF00002458314 CEL 69.8 MB
EGAF00002458315 CEL 69.6 MB
EGAF00002458316 CEL 69.6 MB
EGAF00002458317 CEL 69.7 MB
EGAF00002458318 CEL 69.6 MB
EGAF00002458319 CEL 69.6 MB
EGAF00002458320 CEL 70.1 MB
EGAF00002458321 CEL 69.4 MB
55 Files (3.9 GB)